A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling-Reference-Cited by-同舟云学术

A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling

Published:2022-01 Issue: Volume:172 Page:106917
ISSN:0026-265X
Container-title:Microchemical Journal
language:en
Short-container-title:Microchemical Journal

Author:

Marzouk Hoda M.,Rezk Mamdouh R.,Gouda Amira S.,Abdel-Megied Ahmed M.

Publisher

Elsevier BV

Subject

Spectroscopy,Analytical Chemistry

Reference22 articles.

1. Role of favipiravir in the treatment of COVID-19;Joshi;Int. J. Infect Dis.,2021

2. Tackling COVID-19 using remdesivir and favipiravir as therapeutic options;Reddy;ChemBioChem,2020

3. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase;Furuta;Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.,2017

4. Favipiravir: a new and emerging antiviral option in COVID-19;Agrawal;Med. J. Armed Forces India,2020

5. Development of forced degradation and stability indicating studies of drugs-a review;Blessy;J. Pharm. Anal.,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of analytical quality by design (AQbD) for stability-indicating method development for quantification of nevirapine and its degradation products;Microchemical Journal;2024-04

2. Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-03

3. Extraction of Covid-19 drug (Favipiravir) from plasma samples by yolk-shell mesoporous silica before HPLC-MS/MS determination;Journal of Pharmaceutical and Biomedical Analysis;2024-02

4. A validated LC-MS/MS method for determination of Molnupiravir and Favipiravir in human plasma; Assessment of the remarkable potential synergistic effect against SARS-CoV-2 Infection: Application to a pharmacokinetic study in healthy Egyptian volunteers;Microchemical Journal;2024-02

5. An Eco-Friendly RP-HPLC Method Development and Validation for Quantification of Favipiravir in Bulk and Tablet Dosage Form Followed by Forced Degradation Study;Journal of Chromatographic Science;2024-01-23